Bioengineered hybrid muscle fiber for regenerative medicine

February 21, 2021

Muscle is the largest organ that accounts for 40% of body mass and plays an essential role in maintaining our lives. Muscle tissue is notable for its unique ability for spontaneous regeneration. However, in serious injuries such as those sustained in car accidents or tumor resection which results in a volumetric muscle loss (VML), the muscle's ability to recover is greatly diminished. Currently, VML treatments comprise surgical interventions with autologous muscle flaps or grafts accompanied by physical therapy. However, surgical procedures often lead to a reduced muscular function, and in some cases result in a complete graft failure. Thus, there is a demand for additional therapeutic options to improve muscle loss recovery.

A promising strategy to improve the functional capacity of the damaged muscle is to induce de novo regeneration of skeletal muscle via the integration of transplanted cells. Diverse types of cells, including satellite cells (muscle stem cells), myoblasts, and mesenchymal stem cells, have been used to treat muscle loss. However, invasive muscle biopsies, poor cell availability, and limited long-term maintenance impede clinical translation, where millions to billions of mature cells may be needed to provide therapeutic benefits.

Another important issue is controlling the three-dimensional microenvironment at the injury site to ensure that the transplanted cells properly differentiate into muscle tissues with desirable structures. A variety of natural and synthetic biomaterials have been used to enhance the survival and maturation of transplanted cells while recruiting host cells for muscle regeneration. However, there are unsolved, long-lasting dilemmas in tissue scaffold development. Natural scaffolds exhibit high cell recognition and cell binding affinity, but often fail to provide mechanical robustness in large lesions or load-bearing tissues that require long-term mechanical support. In contrast, synthetic scaffolds provide a precisely engineered alternative with tunable mechanical and physical properties, as well as tailored structures and biochemical compositions, but are often hampered by lack of cell recruitment and poor integration with host tissue.

To overcome these challenges, a research team at the Center for Nanomedicine within the Institute for Basic Science (IBS) in Seoul, South Korea, Yonsei University, and the Massachusetts Institute of Technology (MIT) devised a novel protocol for artificial muscle regeneration. The team achieved effective treatment of VML in a mouse model by employing direct cell reprogramming technology in combination with a natural-synthetic hybrid scaffold.

Direct cell reprogramming, also called direct conversion, is an efficient strategy that provides effective cell therapy because it allows the rapid generation of patient-specific target cells using autologous cells from the tissue biopsy. Fibroblasts are the cells that are commonly found within the connective tissues, and they are extensively involved in wound healing. As the fibroblasts are not terminally differentiated cells, it is possible to turn them into induced myogenic progenitor cells (iMPCs) using several different transcription factors. Herein, this strategy was applied to provide iMPC for muscle tissue engineering.

In order to provide structural support for the proliferating muscle cells, polycaprolactone (PCL), was chosen as a material for the fabrication of a porous scaffold due to its high biocompatibility. While salt-leaching is a widely used method to create porous materials, it is mostly limited to producing closed porous structures. To overcome this limitation, the researchers augmented the conventional salt leaching method with thermal drawing to produce customized PCL fiber scaffolds. This technique facilitated high-throughput fabrication of porous fibers with controlled stiffness, porosity, and dimensions that enable precise tailoring of the scaffolds to the injury sites.

However, the synthetic PCL fiber scaffolds alone do not provide optimal biochemical and local mechanical cues that mimic muscle-specific microenvironment. Hence the construction of a hybrid scaffold was completed through the incorporation of decellularized muscle extracellular matrix (MEM) hydrogel into the PCL structure. Currently, MEM is one of the most widely used natural biomaterials for the treatment of VML in clinical practice. Thus, the researchers believe that hybrid scaffolds engineered with MEM have a huge potential in clinical applications.

The resultant bioengineered muscle fiber constructs showed mechanical stiffness similar to that of muscle tissues and exhibited enhanced muscle differentiation and elongated muscle alignment in vitro. Furthermore, implantation of bioengineered muscle constructs in the VML mouse model not only promoted muscle regeneration with increased innervation and angiogenesis but also facilitated the functional recovery of damaged muscles. The research team notes: "The hybrid muscle construct might have guided the responses of exogenously added reprogrammed muscle cells and infiltrating host cell populations to enhance functional muscle regeneration by orchestrating differentiation, paracrine effect, and constructive tissue remodeling."

Prof. CHO Seung-Woo from the IBS Center for Nanomedicine and Yonsei University College of Life Science and Biotechnology who led this study notes: "Further studies are required to elucidate the mechanisms of muscle regeneration by our hybrid constructs and to empower the clinical translation of cell-instructive delivery platforms."
-end-


Institute for Basic Science

Related Muscle Tissue Articles from Brightsurf:

Different response of mitochondrial respiration in skeletal muscle and adipose tissue to endurance e
In obese individuals, endurance exercise improves fitness and increases the number of mitochondria * and cellular respiration in skeletal muscles.

Muscle aging: Stronger for longer
With life expectancy increasing, age-related diseases are also on the rise, including sarcopenia, the loss of muscle mass due to aging.

Good news: European sea bass absorb virtually no microplastic in their muscle tissue
Laboratory study: AWI researchers gave young European see bass feed laced with microplastic for months, but found virtually no microplastic particles in the fish fillets.

Fantastic muscle proteins and where to find them
Setting out to identify all proteins that make up the sarcomere, the basic contractile unit of muscle cells, resulted in an unexpected revelation, providing experimental evidence that helps explain a fundamental mystery about how muscles work.

Research reveals insights into bioprinted skeletal muscle tissue models
SUTD collaborates with NTU to provide in-depth analysis of 3D in vitro biomimetic skeletal muscle tissue models, highlighting the great potential of bioprinting technology.

Link between gut microbes & muscle growth suggests future approach to tackle muscle loss
Scientists led by NTU Singapore's Professor Sven Pettersson established a link between gut microbes and muscle growth and function -- a finding that could open new doors to interventions for age-related skeletal muscle loss.

Chloride-channel in muscle cells provides new insights for muscle diseases
Researchers from the University of Copenhagen have mapped the structure of an important channel in human muscle cells.

How do muscle and tendon connections last a lifetime?
Muscles are connected to tendons to power animal movements such as running, swimming or flying.

Oscillation in muscle tissue
When a muscle grows or a muscle injury heals, some of the stem cells develop into new muscle cells.

How diabetes causes muscle loss
Diabetes is associated with various health problems including decline in skeletal muscle mass.

Read More: Muscle Tissue News and Muscle Tissue Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.